Shearman & Sterling represented Morgan Stanley & Co. LLC, BofA Securities, Inc. and Cowen and Company, LLC as representatives of the underwriters in connection with the offering by selling shareholders of 2,243,000 American Depositary Shares (ADSs), each representing one Class A ordinary share of Burning Rock Biotech Limited, which is listed on NASDAQ, for a total consideration of approximately $57.76 million.
Headquartered in China, Burning Rock Biotech Limited is a biotech company which focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients and cancer early detection.
The Shearman & Sterling team was led by partners Kyungwon (Won) Lee and Max Hua; associate Leo Wong; and legal assistant Hayley Law (all Hong Kong-Capital Markets).
NOTES TO EDITORS:
About Shearman & Sterling:
With more than 850 lawyers in 24 offices, Shearman & Sterling is a global law firm that partners with corporations, major financial institutions, emerging growth companies, governments and state-owned enterprises to provide the legal and industry insight needed to navigate the challenges of today and achieve their ambitions of tomorrow. Our lawyers come from some 80 countries and speak more than 60 languages.